Charles Brigden

Chief Executive Officer at Eliptica Ltd.

Health Technology

Consumer Services

Commercial Services

Charles Brigden active positions

Companies	Position	Start	End
Eliptica Ltd. Eliptica Ltd. Miscellaneous Commercial ServicesCommercial Services Eliptica Ltd. is a British company that specializes in research and experimental development on biotechnology. The private company was founded in 2022 by Markus Ralser, Aleksej Zelezniak, Charles Brigden. Charles Brigden has been the CEO since 2022.	Chief Executive Officer	2022-03-31	-
	Founder	2022-03-31	-

Companies	Position	Start	End
BTG	Corporate Officer/Principal	2014-04-30	-

Columbia Business School

Masters Business Admin

International

United Kingdom	3
United States	2

Operational

Corporate Officer/Principal	1
Masters Business Admin	1
Chief Executive Officer	1

Sectoral

Positions held

Active

Inactive

Listed companies

Private companies

Private companies	2
BTG Ltd. BTG Ltd. Pharmaceuticals: MajorHealth Technology BTG Ltd. is a global healthcare company, which focuses on interventional medicine that can help physicians to treat patients through minimally invasive procedures. It operates through the following segments: Product, Licensing, and Other. The firm's products include CroFab, DigiFab, Voraxage. The company was founded on December 12, 1991 and is headquartered in Farnham, the United Kingdom.	Health Technology
Eliptica Ltd. Eliptica Ltd. Miscellaneous Commercial ServicesCommercial Services Eliptica Ltd. is a British company that specializes in research and experimental development on biotechnology. The private company was founded in 2022 by Markus Ralser, Aleksej Zelezniak, Charles Brigden. Charles Brigden has been the CEO since 2022.	Commercial Services

Private companies

Health Technology

Commercial Services